ApoA-I mimetics favorably impact cyclooxygenase 2 and bioactive lipids that may contribute to cardiometabolic syndrome in chronic treated HIV

OBJECTIVE: We investigated whether apolipoprotein A-I (apoA-I) mimetic peptides 4F and 6F can be a novel therapeutic strategy to reduce blood and gut bioactive lipids, proinflammatory effects of endotoxin (LPS) and aberrant activation of cyclooxygenase 2 (COX-2) as instigators of increased risk for...

Descripción completa

Detalles Bibliográficos
Autores principales: Daskou, M., Sharma, M., Mu, W., Heymans, R., Ritou, E., Rezek, V., Hamid, P., Kossyvakis, A., Sen Roy, S., Grijalva, V., Chattopadhyay, A., Papesh, J., Meriwether, D., Kitchen, S.G., Fogelman, A.M., Reddy, S.T., Kelesidis, T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8802211/
https://www.ncbi.nlm.nih.gov/pubmed/34509494
http://dx.doi.org/10.1016/j.metabol.2021.154888

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8802211/
https://www.ncbi.nlm.nih.gov/pubmed/34509494
http://dx.doi.org/10.1016/j.metabol.2021.154888

Ejemplares similares